difference between tirzepatide and semaglutide for weight loss vs Tirzepatide: Key Differences Semaglutide Vs Tirzepatide Vs Retatrutide
Description
Interactions with hypoglycemic medications Using retatrutide with insulin or sulfonylureas increases risk of hypoglycemia
Patients in the dataset had a 2.56 times higher rate of developing NAION within 1 year after starting a GLP-1 receptor agonist than those in the dataset who started a dipeptidyl peptidase-4 (DPP-4) inhibitor
W.TezapsidisN
10.4239/wjd.v14.i5.585 105 SchernthanerG.SchernthanerG.-H
It's an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors to produce significant weight loss and improve metabolic health
